nejm tirzepatide / Niacinamide – WP Pharma Labs Head-to-Head: Tirzepatide Outperforms Semaglutide |

Cureus 15 (4), e37080

Were going to target the eye, glaucoma first, but that will pave the way for other rejuvenation processes, whether its rebuilding a new liver, skin, spleen the sky is the limit at this point

A further dimension emerged in May 2026, when the ATTAIN-MAINTAIN trial, published in Nature Medicine , found that patients who switched to orforglipron after achieving substantial weight loss on injectable GLP-1s maintained approximately 7580% of that weight reduction

This can be difficult for those unable to leave their homes

In a National Institutes of Health-funded study published in the Annals of Internal Medicine on Feb